These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9083163

  • 1. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
    Tartour E, Deneux L, Mosseri V, Jaulerry C, Brunin F, Point D, Validire P, Dubray B, Fridman WH, Rodriguez J.
    Cancer; 1997 Apr 01; 79(7):1401-8. PubMed ID: 9083163
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, Teknos TN.
    Cancer; 2008 Aug 15; 113(4):750-7. PubMed ID: 18536030
    [Abstract] [Full Text] [Related]

  • 3. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P, Kamińska J, Kowalska M, Ruka W, Steffen J.
    J Surg Oncol; 2003 Nov 15; 84(3):151-9. PubMed ID: 14598359
    [Abstract] [Full Text] [Related]

  • 4. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
    Heimdal JH, Aarstad HJ, Olofsson J.
    Laryngoscope; 2000 Mar 15; 110(3 Pt 1):402-7. PubMed ID: 10718427
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F, Zaiss I, Herzog D, Götte K, Naim R, Hörmann K.
    Anticancer Res; 2005 Mar 15; 25(4):2761-5. PubMed ID: 16080523
    [Abstract] [Full Text] [Related]

  • 6. Soluble Tie-2 receptor levels independently predict locoregional recurrence in head and neck squamous cell carcinoma.
    Homer JJ, Greenman J, Drevs J, Marme D, Stafford ND.
    Head Neck; 2002 Aug 15; 24(8):773-8. PubMed ID: 12203803
    [Abstract] [Full Text] [Related]

  • 7. Serum prognostic markers in head and neck cancer.
    Meyer F, Samson E, Douville P, Duchesne T, Liu G, Bairati I.
    Clin Cancer Res; 2010 Feb 01; 16(3):1008-15. PubMed ID: 20103685
    [Abstract] [Full Text] [Related]

  • 8. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR.
    Cancer; 1999 Nov 01; 86(9):1700-11. PubMed ID: 10547542
    [Abstract] [Full Text] [Related]

  • 9. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
    Iglesias J, Marik PE, Levine JS, Norasept II Study Investigators.
    Am J Kidney Dis; 2003 Jan 01; 41(1):62-75. PubMed ID: 12500222
    [Abstract] [Full Text] [Related]

  • 10. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ, Adachi I.
    Anticancer Res; 1999 Jan 01; 19(2B):1427-32. PubMed ID: 10365118
    [Abstract] [Full Text] [Related]

  • 11. Influence of locoregional radiation treatment on tumor necrosis factor-alpha and interleukin-6 in the serum of patients with head and neck cancer.
    Akmansu M, Unsal D, Bora H, Elbeg S.
    Cytokine; 2005 Jul 07; 31(1):41-5. PubMed ID: 15878671
    [Abstract] [Full Text] [Related]

  • 12. Effect of education level on outcome of patients treated on Radiation Therapy Oncology Group Protocol 90-03.
    Konski A, Berkey BA, Kian Ang K, Fu KK.
    Cancer; 2003 Oct 01; 98(7):1497-503. PubMed ID: 14508838
    [Abstract] [Full Text] [Related]

  • 13. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R, Grant B, Berkey BA, Raben D, Ang KK, Fu KK, Cooper JS, Radiation Therapy Oncology Group.
    Head Neck; 2006 Apr 01; 28(4):287-96. PubMed ID: 16287132
    [Abstract] [Full Text] [Related]

  • 14. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
    Siddiqui F, Pajak TF, Watkins-Bruner D, Konski AA, Coyne JC, Gwede CK, Garden AS, Spencer SA, Jones C, Movsas B.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):353-60. PubMed ID: 17889449
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
    Wang LS, Chow KC, Li WY, Liu CC, Wu YC, Huang MH.
    Clin Cancer Res; 2000 Apr 01; 6(4):1445-51. PubMed ID: 10778976
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
    van den Broek GB, Rasch CR, Pameijer FA, Peter E, van den Brekel MW, Tan IB, Schornagel JH, de Bois JA, Zijp LJ, Balm AJ.
    Cancer; 2004 Oct 15; 101(8):1809-17. PubMed ID: 15386309
    [Abstract] [Full Text] [Related]

  • 17. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P, Adelstein DJ, Myles J, Secic M.
    Laryngoscope; 2001 Nov 15; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C.
    Clin Cancer Res; 1999 Jun 15; 5(6):1369-79. PubMed ID: 10389921
    [Abstract] [Full Text] [Related]

  • 20. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma.
    Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG.
    Head Neck; 2002 Nov 15; 24(11):1004-11. PubMed ID: 12410536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.